Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL946547 | 0.85 | TSHR (0.53) | TSHRMEN1KMT2AALDH1A1GLA | |
| SCHEMBL10619595 | 0.85 | ALDH1A1 (0.57) | TSHRMEN1KMT2AALDH1A1GLA | |
| SCHEMBL9307563 | 0.84 | TSHR (0.42) | TSHRMEN1KMT2AALDH1A1POLB | |
| SCHEMBL5932535 | 0.83 | TSHR (0.51) | TSHRMEN1KMT2AALDH1A1GLA | |
| SCHEMBL7504930 | 0.82 | TSHR (0.48) | TSHRMEN1KMT2AALDH1A1GLA | |
| SCHEMBL27893727 | 0.82 | TSHR (0.48) | TSHRMEN1KMT2AALDH1A1GLA | |
| SCHEMBL10347920 | 0.82 | ALDH1A1 (0.46) | TSHRMEN1KMT2AALDH1A1GLA | |
| SCHEMBL3465939 | 0.82 | TP53 (0.45) | TSHRMEN1KMT2AALDH1A1GLA | |
| SCHEMBL8035000 | 0.81 | TSHR (0.50) | TSHRMEN1KMT2AALDH1A1GLA | |
| SCHEMBL5933100 | 0.81 | TSHR (0.50) | TSHRMEN1KMT2AALDH1A1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118344633-A | Preparation method of copper-free composite resin brake pad | 浙江万赛汽车零部件股份有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-115627002-B | Epoxy prepreg formula and preparation method and application thereof | 台州市黄岩区武汉理工高性能复合材料技术研究院 | 2024-02-13 | — | — | CN | claimed |
| CN-115627002-A | Formula, preparation method and application of epoxy prepreg | 台州市黄岩区武汉理工高性能复合材料技术研究院 | 2023-01-20 | — | — | CN | claimed |
| CN-107108537-B | Partial stream distillation | 巴斯夫欧洲公司 | 2020-04-17 | — | — | CN | claimed |
| US-20090163480-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | DR. KARL THOMAE GMBH (DE) | 2009-06-25 | — | — | US | claimed |
| US-20040214819-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | DR. KARL THOMAE GMBH (DE) | 2004-10-28 | — | — | US | claimed |
| US-20030069231-A1 | Modified aminoacids, pharmaceuticals containing these compounds and method for their production | RUDOLF KLAUS (DE) | 2003-04-10 | — | — | US | claimed |
| US-20010036946-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | RUDOLF KLAUS (DE) | 2001-11-01 | — | — | US | claimed |
| US-5015762-A | Alkoxy substituted ureas as herbicides | BASF AKTIENGESELLSCHAFT (DE) | 1991-05-14 | — | — | US | claimed |
| US-4025624-A | Phenylalkylamines and phenylalkylureas in combinations to suppress gastric bleeding in aspirin therapy | A. H. ROBINS COMPANY, INCORPORATED (US) | 1977-05-24 | — | — | US | claimed |
| CN-118344633-A | Preparation method of copper-free composite resin brake pad | 浙江万赛汽车零部件股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-115627002-B | Epoxy prepreg formula and preparation method and application thereof | 台州市黄岩区武汉理工高性能复合材料技术研究院 | 2024-02-13 | — | — | CN | disclosed |
| CN-115627002-A | Formula, preparation method and application of epoxy prepreg | 台州市黄岩区武汉理工高性能复合材料技术研究院 | 2023-01-20 | — | — | CN | disclosed |
| CN-109071475-B | Method for preparing propylene oxide | 巴斯夫欧洲公司 | 2022-12-27 | — | — | CN | disclosed |
| CN-107108537-B | Partial stream distillation | 巴斯夫欧洲公司 | 2020-04-17 | — | — | CN | disclosed |
| US-5442060-A | Treating hyperlipemia, atherosclerosis | MITSUBISHI KASEI CORPORATION (JP) | 1995-08-15 | — | — | US | disclosed |
| EP-0591830-A1 | Carboxamide and urea derivatives having ACAT-inhibiting activityM | Mitsubishi Chemical Corporation (JP) | 1994-04-13 | — | — | EP | disclosed |
| US-4025624-A | Phenylalkylamines and phenylalkylureas in combinations to suppress gastric bleeding in aspirin therapy | A. H. ROBINS COMPANY, INCORPORATED (US) | 1977-05-24 | — | — | US | disclosed |
| US-4025624-A | Phenylalkylamines and phenylalkylureas in combinations to suppress gastric bleeding in aspirin therapy | A. H. ROBINS COMPANY, INCORPORATED (US) | 1977-05-24 | — | — | US | disclosed |
| US-4025624-A | Phenylalkylamines and phenylalkylureas in combinations to suppress gastric bleeding in aspirin therapy | A. H. ROBINS COMPANY, INCORPORATED (US) | 1977-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163480-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | PTMS, CHRM1, SRMS | TSHR 181/4885MEN1 596/4885KMT2A 2685/4885 |
| US-20040214819-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | PTMS, SRMS, OPRM1 | TSHR 304/4885MEN1 790/4885KMT2A 2655/4885 |
| US-20030069231-A1 | Modified aminoacids, pharmaceuticals containing these compounds and method for their production | SLC1A5, NEFM, SRMS | TSHR 342/4885MEN1 984/4885KMT2A 2610/4885 |
| US-20010036946-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | PTMS, SRMS, OPRM1 | TSHR 304/4885MEN1 790/4885KMT2A 2655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.